TY - JOUR
T1 - Special features of SARS-CoV-2 in daily practice
AU - Charitos, Ioannis A.
AU - Ballini, Andrea
AU - Bottalico, Lucrezia
AU - Cantore, Stefania
AU - Passarelli, Pier Carmine
AU - Inchingolo, Francesco
AU - D'Addona, Antonio
AU - Santacroce, Luigi
PY - 2020
Y1 - 2020
N2 - The severe acute respiratory syndrome-coronavirus-2 (commonly known as SARS-CoV-2) is a novel coronavirus (designated as 2019-nCoV), which was isolated for the first time after the Chinese health authorities reported a cluster of pneumonia cases in Wuhan, China in December 2019. Optimal management of the Coronavirus Disease-2019 disease is evolving quickly and treatment guidelines, based on scientific evidence and experts' opinions with clinical experience, are constantly being updated. On January 30, 2020, the World Health Organization declared the SARS-CoV-2 outbreak as a "Public Health Emergency of International Concern". The total lack of immune protection brought about a severe spread of the contagion all over the world. For this reason, diagnostic tools, patient management and therapeutic approaches have been tested along the way, in the desperate race to break free from the widespread infection and its fatal respiratory complications. Current medical knowledge and research on severe and critical patients' management and experimental treatments are still evolving, but several protocols on minimizing risk of infection among the general population, patients and healthcare workers have been approved and diffused by International Health Authorities.
AB - The severe acute respiratory syndrome-coronavirus-2 (commonly known as SARS-CoV-2) is a novel coronavirus (designated as 2019-nCoV), which was isolated for the first time after the Chinese health authorities reported a cluster of pneumonia cases in Wuhan, China in December 2019. Optimal management of the Coronavirus Disease-2019 disease is evolving quickly and treatment guidelines, based on scientific evidence and experts' opinions with clinical experience, are constantly being updated. On January 30, 2020, the World Health Organization declared the SARS-CoV-2 outbreak as a "Public Health Emergency of International Concern". The total lack of immune protection brought about a severe spread of the contagion all over the world. For this reason, diagnostic tools, patient management and therapeutic approaches have been tested along the way, in the desperate race to break free from the widespread infection and its fatal respiratory complications. Current medical knowledge and research on severe and critical patients' management and experimental treatments are still evolving, but several protocols on minimizing risk of infection among the general population, patients and healthcare workers have been approved and diffused by International Health Authorities.
KW - Acute respiratory distress syndrome
KW - Antivirals
KW - Clinical biochemistry
KW - Clinical microbiology
KW - Emergency and critical care medicine
KW - Pandemics
KW - SARS-CoV-2/COVID-19
KW - Sepsis
KW - Translational medicine
KW - Viruses
KW - Acute respiratory distress syndrome
KW - Antivirals
KW - Clinical biochemistry
KW - Clinical microbiology
KW - Emergency and critical care medicine
KW - Pandemics
KW - SARS-CoV-2/COVID-19
KW - Sepsis
KW - Translational medicine
KW - Viruses
UR - http://hdl.handle.net/10807/169992
U2 - 10.12998/wjcc.v8.i18.3920
DO - 10.12998/wjcc.v8.i18.3920
M3 - Article
SN - 2307-8960
VL - 8
SP - 3920
EP - 3933
JO - World Journal of Clinical Cases
JF - World Journal of Clinical Cases
ER -